Bupropion HCL ER
View on SAM.gov ↗ Sign in to save
- Type
- Contract
- Notice type
- Award Notice
- Agency
- DEPT OF DEFENSE
- Sub-agency
- DEFENSE LOGISTICS AGENCY
- Office
- DLA TROOP SUPPORT
- Solicitation #
- SPE2D2-23-D-0002
- Posted
- Sep 14, 2026
- Archive date
- Oct 6, 2028
- NAICS
- 325412
- PSC
- 6505
- Place of performance
- Hauppauge, NY, 11788, USA
- Award amount
- $23,278,524
- Awardee
- RADHA PHARMACEUTICALS INC Hauppauge NY 11788 USA
- Contact
- Kyle Lewicki · kyle.lewicki@dla.mil · 4457370977
- Source
- SAM.gov
Description
Modification P00010 SPE2D223D0002 is issued to invoke option year 4 for Bupropion HCL ER National Contract. Modification P00009 SPE2D223D0002 is issued to incorporate clause 52.222-90, Addressing DEI Discrimination by Federal Contractors (DEVIATION 2026-O0040, REVISION 1) (APR 2026). Modification P00008 SPE2D223D0002 is issued to invoke option year 3 for Bupropion HCL ER National Contract. Modification P00007 SPE2D223D0002 is issued in accordance with DoD Class Deviation 2025-O0003 and Class Deviation 2025-O0004 into subject solicitation. Modification P00006 SPE2D223D0002 is issued to invoke option year 2 for Bupropion HCL ER National Contract. Modification P00005 SPE2D223D0002 is issued to incorporate FAR 52.204-30 Federal Acquisition Supply Chain Security Act Orders into subject solicitation. NATIONAL CONTRACT SPE2D2-23-D-0002 BUPROPION HCL ER